US President Trump has signed an executive order designed to lower the cost of prescription drug prices, which includes a win for manufacturers of small molecule drugs. The order comes one day after the Trump administration instituted a national security report into the pharmaceutical industry, which is likely to be followed by tariffs on the […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!